OLI Premium: Comprehensive PDF Reports on Stock Splits & more

Slide 1. OncoSec Medical Incorporated (NASDAQ:ONCS)1 for 10 Reverse Split

OncoSec Medical is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. Co.s primary platform technology, ImmunoPulse, is a drug-device therapeutic modality comprised of a proprietary intratumoral electroporation delivery device. The ImmunoPulse platform is designed to deliver DNA-encoded drugs directly into a solid tumor and promote an inflammatory response against cancer. Co.s main product candidate, ImmunoPulse IL-12, uses Co.s electroporation device to deliver a DNA-encoded interleukin-12 (IL-12), called tavokinogene telseplasmid.

ONCS Detailed Information Page & Split History

Open the ONCS Page at The Online Investor (in a new window)

in this Slideshow: Ticker Stock Split Announced Record Date Pay Date Optionable TROV 1 for 6 2/19/2019 2/19/2019 2/20/2019 No MLNT 1 for 5 2/21/2019 2/21/2019 2/22/2019 Yes XSPA 1 for 20 2/22/2019 2/22/2019 2/25/2019 Yes RBZ 1 for 8 3/14/2019 3/14/2019 3/15/2019 No OTLK 1 for 8 3/15/2019 3/15/2019 3/18/2019 No ATIS 1 for 8 3/15/2019 3/15/2019 3/18/2019 No CRMD 1 for 5 3/25/2019 3/25/2019 3/26/2019 Yes NSPR 1 for 50 3/26/2019 3/29/2019 4/1/2019 No HOV 1 for 25 3/29/2019 3/29/2019 3/29/2019 Yes MARA 4 for 1 4/5/2019 4/5/2019 4/8/2019 Yes MOXC 1 for 5 4/5/2019 4/19/2019 4/22/2019 No RNN 1 for 12 4/10/2019 4/12/2019 4/12/2019 Yes BPMX 1 for 25 4/15/2019 4/25/2019 4/26/2019 No FAST 2 for 1 4/18/2019 5/2/2019 5/22/2019 Yes ARCI 1 for 5 4/18/2019 4/19/2019 4/22/2019 No DAC 1 for 14 4/22/2019 5/1/2019 5/2/2019 No FFIN 2 for 1 4/23/2019 6/17/2019 7/1/2019 Yes NMM 1 for 15 4/25/2019 5/21/2019 5/21/2019 Yes EARS 1 for 20 4/30/2019 4/30/2019 5/1/2019 No DMPI 1 for 10 5/7/2019 5/7/2019 5/8/2019 No FCEL 1 for 12 5/8/2019 5/8/2019 5/9/2019 Yes NVAX 1 for 20 5/8/2019 5/10/2019 5/10/2019 Yes VISL 1 for 10 5/10/2019 5/10/2019 5/13/2019 No VLRX 1 for 20 5/17/2019 5/17/2019 5/20/2019 No ONCS 1 for 10 5/20/2019 5/20/2019 5/21/2019 No

(ranked lower than approx. 64% of all stocks covered)

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the followingFull Disclaimer & Terms of UseandPrivacy Policy.Video widgetand stock market videos powered byMarket News Video. Quote data delayed at least 20 minutes,powered by Ticker Technologies, ntact The Online Investor;Meet Our Editorial Staff.